Stock Analysis on Net
Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

Eli Lilly & Co. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Eli Lilly & Co., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net income (loss)
Depreciation and amortization
Change in deferred income taxes
Debt extinguishment loss
Stock-based compensation expense
Gains on sale of product rights
Acquired in-process research and development
Other changes in operating assets and liabilities, net of acquisitions and divestitures
Other operating activities, net
Adjustments to reconcile net income (loss) to cash flows from operating activities
Net cash provided by operating activities
Purchases of property and equipment
Proceeds from sales of and distributions from noncurrent investments
Purchases of noncurrent investments
Proceeds from sale of product rights
Purchases of in-process research and development
Cash paid for acquisitions, net of cash acquired
Other investing activities, net
Net cash used for investing activities
Dividends paid
Net change in short-term borrowings
Proceeds from issuance of long-term debt
Repayments of long-term debt
Purchases of common stock
Other financing activities, net
Net cash provided by (used for) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The financial data indicates a period of significant expansion and operational scaling, characterized by a substantial long-term increase in net income and a corresponding escalation in capital expenditures. While quarterly volatility is present, the overall trajectory suggests a transition toward a higher baseline of profitability and investment.

Operating Performance and Cash Generation
Net income demonstrates a strong upward trend, rising from 1,355 million US$ in March 2021 to 7,396 million US$ by March 2026. This growth is mirrored in the net cash provided by operating activities, which, despite a notable contraction to -312 million US$ in December 2023, reached a peak of 8,836 million US$ in September 2025. The reconciliation of net income to operating cash flow reveals significant fluctuations in deferred income taxes and other operating assets and liabilities, suggesting complex timing differences in tax recognition and working capital management.
Investment Strategy and Capital Expenditures
A consistent and accelerating commitment to infrastructure and research is evident. Purchases of property and equipment increased nearly eightfold, moving from 300 million US$ in March 2021 to 2,326 million US$ in March 2026. Investment in in-process research and development (IPRD) remained a primary driver of cash outflows, with periodic spikes such as the 3,031 million US$ expenditure in September 2023. The net cash used for investing activities has trended upward, reflecting an aggressive strategy of capacity expansion and pipeline development.
Financing Activities and Capital Structure
The company utilizes a combination of long-term debt issuance and operational cash to fund its growth and shareholder returns. Large-scale debt issuances occurred periodically, notably 6,453 million US$ in March 2024 and 6,706 million US$ in June 2025. Shareholder distributions have remained a priority, with quarterly dividend payments steadily increasing from 775 million US$ in March 2021 to 1,548 million US$ in March 2026. Additionally, common stock repurchases became more frequent and larger in volume toward the end of the period, reaching 2,356 million US$ in March 2026.
Liquidity and Cash Position
The net change in cash and cash equivalents exhibits high variability due to the timing of large debt draws and major investment outlays. The significant cash inflow of 6,416 million US$ in September 2025 highlights a period of high liquidity, which was subsequently utilized for increased investments and financing outflows in the following quarters.